AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Benchtop bioreactors market seen reaching $1.75 billion by 2030
AGP
The global benchtop bioreactors market is expected to grow from $1.19 billion in 2026 to $1.75 billion by 2030, driven by biologics, biosimilars, and gene therapy research.
Conjunctivitis treatment market projected to reach $6.13B by 2030
AGP
The global conjunctivitis treatment market is set to grow from $5.1 billion in 2026 to $6.13 billion by 2030, according to The Business Research Company.
Biguanides market to reach $5.97 billion by 2030
AGP
The global biguanides market is projected to grow from $5.11 billion in 2025 to $5.28 billion in 2026, as demand rises for diabetes and metabolic disorder treatments.
Supemtek market set to grow on flu demand and vaccine innovation
AGP
The Business Research Company says the global Supemtek market is gaining from rising flu burden, stronger vaccination rates and broader interest in recombinant, egg-free vaccines.
Payment Options taps Tribe Payments for acquirer processing across Asia-Pacific
AGP
Singapore-based Payment Options has chosen Tribe Payments to power payment processing for its acquiring business as the company expands direct Visa and Mastercard acquiring in Asia-Pacific and CEMEA. The rollout starts in Mauritius, where Payment…
Blood cancer drugs market to reach $111.86 billion by 2030
AGP
The global blood cancer drugs market is projected to grow from $84.59 billion in 2026 to $111.86 billion by 2030, according to The Business Research Company.
Benzodiazepine drugs market seen reaching $5.07 billion by 2030
AGP
The benzodiazepine drugs market is projected to grow from $4.01 billion in 2026 to $5.07 billion by 2030, according to The Business Research Company.
Simulect market outlook points to transplant demand and regional growth
AGP
A new report from The Business Research Company says the Simulect market is expanding as kidney disease cases, organ transplants and biologic immunosuppression use rise.
Repatha market forecast points to faster growth in Asia-Pacific
AGP
The Business Research Company says the Repatha market is set to expand through 2035, driven by rising cardiovascular disease, high cholesterol and obesity rates.
Rekovelle market report flags IVF demand and regional growth shifts
AGP
The Business Research Company says the global Rekovelle market will keep expanding through 2035, driven by rising infertility rates, more IVF procedures and broader use of personalized fertility treatment.
Repronex market report flags fertility demand and regional growth
AGP
The Business Research Company says the global Repronex market is being lifted by rising infertility, delayed childbearing and broader access to fertility care.
Bisoprolol market seen rising to $3.26 billion by 2030
AGP
The Business Research Company says the global bisoprolol market will grow from $2.17 billion in 2025 to $2.35 billion in 2026, then reach $3.26 billion by 2030. The forecast points to stronger demand for cardiovascular treatment as hypertension…
Sotrovimab market report points to faster growth in Asia-Pacific
AGP
The Business Research Company says the global sotrovimab, or Xevudy, market will be shaped by COVID-19 infection rates, healthcare spending and demand for variant-resistant therapies through 2035. North America led the market in 2025, while…
Behçet’s disease market seen reaching $1.8 billion by 2030
AGP
The Behçet’s disease market is projected to grow from $1.24 billion in 2025 to $1.8 billion by 2030 as biologic therapies, earlier diagnosis and rare-disease investment expand treatment demand.
Rylaze market forecast points to faster growth in Asia-Pacific
AGP
The Business Research Company says the Rylaze market is set to expand through 2035 as oncology biologics spending rises, personalized medicine gains ground, and leukemia treatment shifts toward recombinant enzymes.
Bisphosphonate drug market seen reaching $7.04 billion by 2030
AGP
The Business Research Company says the global bisphosphonate drug market is expanding on rising osteoporosis cases, an aging population and broader use of injectable therapies.
Biotech ingredient market seen reaching $87.06 billion by 2030
AGP
The biotech ingredient market is projected to rise from $63.25 billion in 2025 to $87.06 billion by 2030, according to a new report from The Business Research Company.
Congenital adrenal hyperplasia market seen reaching $0.7 billion by 2030
AGP
The congenital adrenal hyperplasia market is projected to grow from $0.5 billion in 2025 to $0.7 billion by 2030, driven by gene therapy interest, broader genetic testing and new steroid formulations.
Cord blood banking services market to reach $39.7 billion by 2030
AGP
The cord blood banking services market is projected to grow from $30.54 billion in 2026 to $39.7 billion by 2030, driven by rising demand for stem cell therapies, genetic treatments and private banking.
Bone pain treatment market seen reaching $8.58 billion by 2030
AGP
The Business Research Company says the global bone pain treatment market will grow from $6.05 billion in 2025 to $8.58 billion by 2030, driven by rising osteoporosis, fractures and broader use of non-opioid therapies.
Sign up for:
Asia News Digest
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.